chevron_leftBack
As of 18 June 2026, Jiangsu Bioperfectus Technologies Co., Ltd. has a market cap of $753.39M USD, ranking #12492 globally and #3733 in China.
It ranks #1141 in the Healthcare sector, and #423 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$753.39MUSD
5.09B CNY
Enterprise Value
$575.33MUSD
3.89B CNY
Revenue (TTM)
$50.17MUSD
339.05M CNY
EBITDA (TTM)
-$1.27MUSD
-8.61M CNY
Net Income (TTM)
-$6.08MUSD
-41.08M CNY
EBITDA Margin
-2.5%
Profit Margin
-12%
PS Ratio
15.0
PB Ratio
1.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Guoqiang Wang
open_in_new
Employees
586
Founded
2010
Website
s-sbio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.7% | -2.4% | 9.2% | -17% | -23% | 37% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
688399
江苏硕世生物科技股份有限公司 Class A
ISIN: CNE1000055B2
Shares Out.:
Shares Outstanding:
83.872M1
Shares Float:
83.868M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
61.75 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Jiangsu Bioperfectus Technologies Co., Ltd.
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. Jiangsu Bioperfectus Technologies Co., Ltd. was founded in 2010 and is headquartered in Taizhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$54.0B
7K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.78B
7K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.53B
4K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.81B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.56B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.02B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
101K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
73K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
48K%
|
97.4
|
|
SIX: RO
|
$323.08B
43K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.5B
38K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.99B
37K%
218.9B CHF
|
20.5
|
chevron_leftBack